Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Cancer Prevention and Treatment
1673-5269
2006 Issue 24
yuan fa xing gan ai de wai ke zhi liao
qin lun xiu ; ren ning
..............page:1921-1924
fen tai ni tou pi tie zhi liao zhong zhong du ai tong lin chuang guan cha
li li na ; li zhong rui ; sun cheng xiang ; li chun yan ; chen zuo quan
..............page:1919-1920
xiong bi fang liao hou zhao she ye fu gai shi fu fa yuan yin fen xi fu san li bao dao
fan ting yong ; li jian bin ; tian shi yu ; chen yan tiao
..............page:1918,1920
zhui guan nei zhong liu 61 li lin chuang fen xi
yang cheng ju
..............page:1917
oxaliplatin lian he lv he 5-fu chi xu jing mai di ru zhi liao wan qi da chang ai de lin chuang guan cha
chen jing li ; song bao guo ; lu yan chun ; chen duo cai ; wu jian xia
..............page:1916
Progress in nucleic acid aptamers for oncology research
ZHANG Fei;NIU Rui-fang
..............page:1911-1914
Transabdominal approach for radical surgery of cardiac cancer
YONG Hai-hong;LIU Wen-feng;QIANG Hua;YANG Xiao-jun
..............page:1909-1910
Clinical analysis of 17 patients with primary orbital lymphoma
SUN San-yuan;YU Da-hai;ZHUO Shi-chao;WANG Hai-wei
..............page:1905-1906,1908
Three-dimensional conformal radiotherapy for 43 patients with metastasis of retroperitoneal lymph node
YU Long-zhen;ZHU Hai-wen;BAI Hui-ming;QIU Hong-yan
..............page:1902-1904
Detection and patterns of internal mammary node metastasis of breast cancer with modified extended radical mastectomy and intercostal exploration
FAN Xi-hong;FAN Zi-yi;HE Qing-qing;ZHANG Xiao-qiao;ZHUANG Da-yong
..............page:1876-1878
Expressions of P-gp and Topo-Ⅱ in endometrial carcinoma and their clinical significance
DUAN Zhao;QU Qun;ZHAO Ling;CHEN Qing-juan;WANG Gui-xian;MA Yu-qin;DU Wen-xia
..............page:1873-1875
Expressions and their clinical significance of PTEN, p27Kip1 and cyclinD1 in hepatocelluar carcinoma
LI Chao;ZHENG Tian-rong;ZHENG Xiong-wei;LU Li-li;LIN Xian-dong
..............page:1869-1872
Expressions of mucin MUC2 and MUC3 in colorectal carcinoma and their clinical significance
YANG Yu-feng;GUO Hong-liang;ZHANG Lei;ZAN Yan-sheng
..............page:1866-1868
Phosphoinositide-3kinase in rectal carcinoma
ZHANG Guo-shuan;YA Jian;ZHENG Zhi-min;CUI Chuan-yi;WANG Gui-qi;GU Jing-feng;DI Hai-bing
..............page:1863-1865
Expressions and clinical significance of Fos and Jun proteins in gastric adenocarcinoma
HOU Ren-hao;CHU Xiao-yi;LIU Xi-shuang
..............page:1860-1862
Effects of survivin ASODN on proliferation in gastric cancer cell line SGC-7901
YIN Xiao-chun;PANG Chun-yan;CHEN Wei
..............page:1856-1859
Research on the radiosensitivity by RNAi targeting RAD51 gene
YU Cheng-yu;PAN Zhen;WANG Chun-gang;MIN Rui;YAO Yu-shi;ZHAO Fang;HAN Ling
..............page:1852-1855
Anti-adhesion of HUVEC to LOVO cell induced by human arresten
LONG Miao-yun;ZHENG Qi-chang;SONG Zi-fang;HU Qing-gang;CHEN Li-bo
..............page:1846-1848
Analysis of the efficacy of different therapeutic methods and prognostic factors in stage ⅠB2 cervical carcinoma
ZENG Si-yuan;LI Long-yu;WU Yun-yan;LIANG Mei-rong
..............page:1899-1901
Role of MSCT in the diagnosis of bladder carcinoma
LI Bao-ping;ZENG Qing-yu;ZHOU Yun-zhi;YIN Xiao-ming;HUO Jian-wei;BAN Run-yi;MA Da-qing;GAO Wen-jie
..............page:1896-1898
Preliminary clinical observation on high intensity focused ultrasound in treatment of portal vein tumor thrombosis
YE Xin;GE Zhong-min;LIU Li-xia;ZOU Yu-hong;FEI Xing-bo;CHENG Yuan-yuan
..............page:1893-1895
Diagnositic value of cell block of liver carcinoma by fine needle aspiation under ultrasonic guidance
CHEN Bing;LIANG Feng-quan;MA Qing-song;Xie Jian-jun;MA Guang-zhen;ZHOU Li;REN Yu-bo
..............page:1890-1892
Comparison of diagnosis value of winding method and simply diseased area method for collecting gastric specimens
QIN Jun;LI Min;SUN Li-juan;ZHU Ming;QIN Yan;WANG Zhen-zhen
..............page:1885-1886
Clinical observation of Gefitinib in the treatment of dominant crowd with non-small cell lung cancer
QIAN Jun;QIN Shu-kui;YANG Liu-qing;CHEN Ying-xia;HE Ze-ming;HUANG Yong
..............page:1882-1884
Correlation between standard uptake value of 18FDG PET/CT and clinical staging of non-small cell lung cancer
MENG Xue;FU Zheng;DU Jie;SUN Xin-dong;YANG Guo-ren;YU Jin-ming
..............page:1879-1881